Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mary Ann Fallon"'
Autor:
Minoo Bakhtiari, Mary Ann Fallon, Joseph J. Eron, Aaron Griffin, Daniel R. Kuritzkes, David Poticha, David Shugarts, Joseph B. Quinn, Sharon L. Benoit, Marc Rubin
Publikováno v:
AIDS. 10:975-981
Objective: To study the effect of HIV-1 resistance to lamivudine (3TC) and zidovudine (ZDV), and syncytium-inducing (SI) phenotype on virologic response to treatment with ZDV, 3TC, or ZDV plus 3TC in previously untreated individuals with HIV-1 infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97c52d5edd8644d49d255919ee498cd7
https://doi.org/10.1097/00002030-199610090-00007
https://doi.org/10.1097/00002030-199610090-00007
Autor:
Mary Ann Fallon, Sharon L. Benoit, Joseph J. Eron, Daniel R. Kuritzkes, Joseph B. Quinn, Rodger D. MacArthur, Jorge Santana, Marc Rubin, Joseph Jemsek
Background. The reverse-transcriptase inhibitor lamivudine has in vitro synergy with zidovudine against the human immunodeficiency virus (HIV). We studied the activity and safety of lamivudine plus zidovudine as compared with either drug alone as tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2caede2bc7781560f841652dd573c605
Autor:
Chris Tsoukas, W. Christopher Ehmann, Marc Rubin, Mary Ann Fallon, John Bartlett, Pamela L. Self, Victoria A. Johnson, Gladys E. Sepulveda, Sharon L. Benoit, Joseph B. Quinn
Publikováno v:
Annals of Internal Medicine. 125:161
Objective : To compare the safety and activity of lamivudine plus zidovudine with the safety and activity of zalcitabine plus zidovudine in patients with moderately advanced human immunodeficiency virus (HIV) infection who had received zidovudine. De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6600cd6559336605fdbee56faff8eb4
https://doi.org/10.7326/0003-4819-125-3-199608010-00001
https://doi.org/10.7326/0003-4819-125-3-199608010-00001